Global and Tropical Health

Medicine and Dentistry

1. Patient 100%
2. Therapeutic Procedure 72%
3. Infection 66%
4. Child 63%
5. Diseases 46%
6. Malaria 46%
7. Diagnosis 38%
8. Hospital 36%
9. Analysis 32%
10. Health 28%
11. Scabies 28%
12. Burkholderia pseudomallei 25%
13. Cohort Effect 24%
14. Adult 21%
15. Rheumatic Heart Disease 20%
16. Randomized Controlled Trial 19%
17. Malaria Falciparum 19%
18. Systematic Review 17%
19. Rheumatic Fever 17%
20. Woman 17%
21. Vaccine 16%
22. Tuberculosis 15%
23. Infant 15%
24. Age 15%
25. Incidence 15%
26. Mortality 14%
27. Public Health 14%
28. Plasmodium Vivax Malaria 13%
29. Laboratory 12%
30. Development 12%
31. COVID-19 11%
32. Sepsis 11%
33. Pneumococcus Vaccine 11%
34. Pneumonia 11%
35. Pregnancy 11%
36. Pathogen 11%
37. Culture 10%
38. Pediatrics 10%
39. Anti-biotics 9%
40. Observational Study 9%
41. Assay 9%
42. Screening 9%
43. Follow up 8%
44. Meta-Analysis 8%
45. Health Care Cost 8%
46. Bloodstream Infection 8%
47. Water 8%
48. Clinical Trial 8%
49. Primary Health Care 8%
50. Cohort Analysis 8%
51. Skin Infection 8%
52. Glucose 6 Phosphate Dehydrogenase 8%
53. Prospective Study 8%
54. Clinician 8%
55. Parasite (Microbiology) 7%
56. Staphylococcus Aureus 7%
57. Experience 7%
58. Impetigo 7%
59. Physician 7%
60. Drug 7%
61. Association 7%
62. Case Report 6%
63. Cross Sectional Study 6%
64. Symptom 6%
65. Lung 6%
66. Nitric Oxide 6%
67. Aboriginal and Torres Strait Islander 6%
68. Influenza 6%
69. Male 6%
70. Prophylaxis 6%
71. Comprehension 5%
72. Hygiene 5%
73. Morbidity 5%
74. Organism 5%
75. Health Service 5%
76. Prospective Cohort Study 5%
77. Human 5%
78. Fever 5%
79. Childhood 5%
80. Microscopy 5%
81. Antibiotic Resistance 5%